Refine by
Test Fitting Articles & Analysis
6 news found
Telehealth use skyrocketed in the early months of the Covid-19 pandemic when many health providers were forced to deliver services remotely. Although telehealth visits have dropped from their peak in 2020, they remain elevated even as many patients return to in-person care, according to the results of an analysis by Epic Research and the Kaiser Family Foundation. Survey results show that ...
Regular participation in colorectal cancer (CRC) screening programmes can reduce the number of colorectal cancer cases as well as mortality rates (Brenner et al., 2014; Zorzi et al., 2015)*. Quantitative Fecal Immunochemical Tests (FIT) are recommended for colorectal cancer population screenings. An advantage of quantitative tests is the ability to vary cut-off values, which allows an adaption to ...
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly, preparation-free, screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's ...
Cority, the most trusted provider of environmental, health, safety and quality (EHSQ) software, today announced the release of two new, rapidly deployable solutions to help businesses manage operational risks and quickly return to work and productivity during COVID-19. Developed on its unified, cloud-based platform, and designed by Cority’s internal experts following recommendations from ...
ByCority
Cority, the most trusted provider of environmental, health, safety, and quality (EHSQ) software today announced the immediate availability of its newly packaged COVID-19 Workplace Health and Continuity Solutions to help organizations effectively manage critical business processes during the graduated easing of restrictions and resumption of regular activities. The post-peak period is anticipated ...
ByCority
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible scanning capsule based system for the prevention of colorectal cancer through the detection of precancerous polyps, today announced positive results from the ...